Patent · US11020458B2 · B2 · US
Factor VIII polymer conjugates
- (11) Publication number
- US11020458B2
- (21) Application number
- 16/285,394
- (22) Filing date
- 2019-02-26
- (30) Priority date
- 2006-03-31
- (43) Publication date
- 2021-06-01
- (45) Date of grant
- 2021-06-01
- (51) IPC
- A61K 38/37; A61K 47/60; A61K 47/61; C07K 14/745
- (52) CPC
- (73) Assignee
- Takeda Pharmaceutical Co Ltd
- (72) Inventors
- Peter Turecek; Juergen Siekmann
- (54) Title
- Factor VIII polymer conjugates
- (57) Abstract
The invention is a proteinaceous construct comprising a Factor VIII molecule which is conjugated to a water-soluble polymer via carbohydrate moieties of Factor VIII, and methods of preparing same.
- Full text
- View on Google Patents
Claims (1)
- A composition comprising: (a) a Factor VIII molecule; and (b) at least one water soluble polymer bound to said Factor VIII molecule, wherein said water soluble polymer is attached to the Factor VIII via an oxidized carbohydrate moiety; wherein said water soluble polymer is selected from the group consisting of polyethylene glycol (PEG), polysialic acid (PSA) and dextran; wherein said water soluble polymer is linear; wherein said water soluble polymer has a molecular weight of 2,000 to 150,000 Da; wherein the Factor VIII is a recombinant Factor VIII; wherein said molecule retains at least 50% of native FVIII activity; and said composition is substantially free from albumin.
Description
This application is a continuation of U.S. application Ser. No. 15/213,802, filed on Jul. 19, 2016, (now abandoned), which is a continuation of U.S. application Ser. No. 14/736,870, filed on Jun. 11, 2015, (now abandoned), which is a continuation of U.S. application Ser. No. 13/756,856, filed Feb. 1, 2013, (now abandoned), which is a continuation of U.S. application Ser. No. 13/243,550, filed Sep. 23, 2011, (now abandoned), which is a continuation of U.S. application Ser. No. 13/010,627, filed Jan. 20, 2011 (now issued as U.S. Pat. No. 8,071,728), which is a divisional of U.S. application Ser. No. 12/684,536, filed Jan. 8, 2010 (now issued as U.S. Pat. No. 8,003,760), which is a divisional of U.S. application Ser. No. 12/184,567, filed Aug. 1, 2008 (now issued as U.S. Pat. No. 7,645,860), which is a continuation-in-part of U.S. application Ser. No. 11/729,625, filed on Mar. 29, 2007, (now issued as U.S. Pat. No. 7,683,158) which claims priority to U.S. Provisional Application Nos. 60/790,239 and 60/787,968, which were filed on Apr. 6, 2006 and Mar. 31, 2006, respectively, and U.S. application Ser. No. 13/010,627, filed Jan. 20, 2011, is a divisional of U.S. application Ser. No. 12/184,567, filed Aug. 1, 2008, (now issued as U.S. Pat. No. 7,645,860).
The present invention relates to a proteinaceous construct comprising coagulation factor VIII (FVIII) being bound to at least one water soluble polymer, including a poly(alkylene oxide) such as polyethylene glycol.
Citations (93)
- US4179337A
- US4356170A
- US4757006A
- US4965199A
- US5618788A
- US4970300A
- WO1986006096A1
- US5198349A
- US5250421A
- US5470954A
- US5470954C1
- EP0306968A2
- US5605884A
- US4877608A
- US5153265A
- US5122614A
- WO1991009122A1
- US5328694A
- US5198493A
- US5492821A
- WO1992016555A1
- US5539063A
- US5565427A
- US5565427C1
- US5846951A
- WO1993000357A1
- US6037452A
- WO1994005332A2
- US5733873A
- US5919766A
- EP0605963A2
- US5298643A
- WO1994015626A1
- WO1994015625A1
- US5621039A
- WO1994029370A1
- US5969040A
- US6566506B2
- WO1996010584A1
- WO1996040731A1
- US6379933B1
- US6048720A
- WO1997011957A1
- EP1260582A1
- EP1258497A2
- US6005077A
- EP0774261A2
- WO1997019701A2
- US6864350B2
- WO1998025969A1
- WO1998038218A1
- US6872393B2
- US6743908B2
- US6183738B1
- EP0977584A1
- US20060286634A1
- US6455639B1
- WO2000023114A2
- US6692931B1
- WO2000049047A1
- WO2000048635A1
- US6586573B1
- WO2001005434A2
- US7338788B2
- US7230081B1
- WO2001037893A1
- US6806063B2
- US6586398B1
- US7118737B2
- US20040247634A1
- US6913915B2
- US20040132640A1
- US20050106658A1
- WO2003040211A2
- US20030143596A1
- US20040235734A1
- WO2004075923A2
- US7199223B2
- WO2004081053A1
- WO2004089280A2
- WO2005032581A2
- WO2005058366A2
- WO2006071801A2
- US20060160948A1
- US7645860B2
- WO2007126808A1
- US20090076237A1
- US20070244301A1
- WO2008025856A2
- WO2008074032A1
- US9492555B2
- US8642737B2
- US20170349644A1
Record as JSON
{
"publication_number": "US11020458B2",
"country": "US",
"kind": "B2",
"title": "Factor VIII polymer conjugates",
"abstract": "The invention is a proteinaceous construct comprising a Factor VIII molecule which is conjugated to a water-soluble polymer via carbohydrate moieties of Factor VIII, and methods of preparing same.",
"claims": [
"1. A composition comprising: (a) a Factor VIII molecule; and (b) at least one water soluble polymer bound to said Factor VIII molecule, wherein said water soluble polymer is attached to the Factor VIII via an oxidized carbohydrate moiety; wherein said water soluble polymer is selected from the group consisting of polyethylene glycol (PEG), polysialic acid (PSA) and dextran; wherein said water soluble polymer is linear; wherein said water soluble polymer has a molecular weight of 2,000 to 150,000 Da; wherein the Factor VIII is a recombinant Factor VIII; wherein said molecule retains at least 50% of native FVIII activity; and said composition is substantially free from albumin."
],
"description_excerpt": "This application is a continuation of U.S. application Ser. No. 15/213,802, filed on Jul. 19, 2016, (now abandoned), which is a continuation of U.S. application Ser. No. 14/736,870, filed on Jun. 11, 2015, (now abandoned), which is a continuation of U.S. application Ser. No. 13/756,856, filed Feb. 1, 2013, (now abandoned), which is a continuation of U.S. application Ser. No. 13/243,550, filed Sep. 23, 2011, (now abandoned), which is a continuation of U.S. application Ser. No. 13/010,627, filed Jan. 20, 2011 (now issued as U.S. Pat. No. 8,071,728), which is a divisional of U.S. application Ser. No. 12/684,536, filed Jan. 8, 2010 (now issued as U.S. Pat. No. 8,003,760), which is a divisional of U.S. application Ser. No. 12/184,567, filed Aug. 1, 2008 (now issued as U.S. Pat. No. 7,645,860), which is a continuation-in-part of U.S. application Ser. No. 11/729,625, filed on Mar. 29, 2007, (now issued as U.S. Pat. No. 7,683,158) which claims priority to U.S. Provisional Application Nos. 60/790,239 and 60/787,968, which were filed on Apr. 6, 2006 and Mar. 31, 2006, respectively, and U.S. application Ser. No. 13/010,627, filed Jan. 20, 2011, is a divisional of U.S. application Ser. No. 12/184,567, filed Aug. 1, 2008, (now issued as U.S. Pat. No. 7,645,860).\n\nThe present invention relates to a proteinaceous construct comprising coagulation factor VIII (FVIII) being bound to at least one water soluble polymer, including a poly(alkylene oxide) such as polyethylene glycol.",
"cpc": [
"A61K 38/37",
"A61K 38/00",
"A61K 38/18",
"A61K 47/50",
"A61K 47/60",
"A61K 47/61",
"A61P 7/00",
"A61P 7/04",
"C07K 14/745",
"C07K 14/755"
],
"ipc": [
"A61K 38/37",
"A61K 47/60",
"A61K 47/61",
"C07K 14/745"
],
"assignees": [
"Takeda Pharmaceutical Co Ltd"
],
"inventors": [
"Peter Turecek",
"Juergen Siekmann"
],
"filing_date": "2019-02-26",
"publication_date": "2021-06-01",
"grant_date": "2021-06-01",
"priority_date": "2006-03-31",
"application_number": "US-201916285394-A",
"family_id": "41404469",
"cited_by_count": 9,
"citations": [
"US4179337A",
"US4356170A",
"US4757006A",
"US4965199A",
"US5618788A",
"US4970300A",
"WO1986006096A1",
"US5198349A",
"US5250421A",
"US5470954A",
"US5470954C1",
"EP0306968A2",
"US5605884A",
"US4877608A",
"US5153265A",
"US5122614A",
"WO1991009122A1",
"US5328694A",
"US5198493A",
"US5492821A",
"WO1992016555A1",
"US5539063A",
"US5565427A",
"US5565427C1",
"US5846951A",
"WO1993000357A1",
"US6037452A",
"WO1994005332A2",
"US5733873A",
"US5919766A",
"EP0605963A2",
"US5298643A",
"WO1994015626A1",
"WO1994015625A1",
"US5621039A",
"WO1994029370A1",
"US5969040A",
"US6566506B2",
"WO1996010584A1",
"WO1996040731A1",
"US6379933B1",
"US6048720A",
"WO1997011957A1",
"EP1260582A1",
"EP1258497A2",
"US6005077A",
"EP0774261A2",
"WO1997019701A2",
"US6864350B2",
"WO1998025969A1",
"WO1998038218A1",
"US6872393B2",
"US6743908B2",
"US6183738B1",
"EP0977584A1",
"US20060286634A1",
"US6455639B1",
"WO2000023114A2",
"US6692931B1",
"WO2000049047A1",
"WO2000048635A1",
"US6586573B1",
"WO2001005434A2",
"US7338788B2",
"US7230081B1",
"WO2001037893A1",
"US6806063B2",
"US6586398B1",
"US7118737B2",
"US20040247634A1",
"US6913915B2",
"US20040132640A1",
"US20050106658A1",
"WO2003040211A2",
"US20030143596A1",
"US20040235734A1",
"WO2004075923A2",
"US7199223B2",
"WO2004081053A1",
"WO2004089280A2",
"WO2005032581A2",
"WO2005058366A2",
"WO2006071801A2",
"US20060160948A1",
"US7645860B2",
"WO2007126808A1",
"US20090076237A1",
"US20070244301A1",
"WO2008025856A2",
"WO2008074032A1",
"US9492555B2",
"US8642737B2",
"US20170349644A1"
]
}
Record 1,617 of 8,000 in Patents full text (MLC-0201). Request the full dataset.